In this segment, the panelists explain that although there is currently no answer to what causes multiple sclerosis (MS), what has been learned can help providers treat MS patients more proactively.
Patricia K. Coyle, MD, says that ideas about the etiology of MS are evolving with genetics, environmental factors, and the host immune system, and discusses the recognized components that may be responsible for MS.
Dr Coyle explains that although inflammation plays a role, there may be a different type of inflammation driving the neuro-degenerative, more disabling phase of MS, compared with the typical relapsing, macroscopic lesions in the white matter phase.
Leslie Fish, PharmD, agrees with Dr Coyle and further explains her feelings about the correlation between inflammation and acute attacks.
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen